Effects of simvastatin on differentiation of osteoblasts derived from human bone marrow stromal cells
Jun Niu
Abstract
Jun Niu
Abstract
AIM:To investigate the effects of simvastatin(SIM)on differentiation of osteoblast derived from the cultured human bone marrow stromal cells(hBMSCs).METHODS:hBMSCs derivedfrom human were cultured in vitro and divided into 2 groups:Control group(G1),SIM group(G2).After subculturing,the medium of treatment group(G2)were added 10-7M simvastatin.Real time RT-PCR was performed to evaluate the mRNA expressionsof BMP-2,Smad1,β-catenin,LRP5,Frizzled2 at day 7,14 and 21 after subculturing;The protein level expression of β-catenin was assessed by immuhistochemistry staining;Alkaline phosphatase staining was used to assess osteoblast differentiation at day 7 after subculturing;Von Kossa staining was used to assess extracellular matrix mineralization and at day 21 after subculturing.RESULTS:The expression levels of mRNA of BMP2 in group G2 were significantly higher than those of group G1 at 3 time points;The expression levels of mRNA of Smad1 in group G2 were significantly higher than those of group G1 at 14 and 21 d subculturing,and the mRNA expression levels of other detected genes showed no significant difference between two groups at each time point.Immuhistochemistry staining:No significant difference was found of the protein expression levels of β-catenin at the 3 time points between the 2 groups.the expression level of ALP and the capability of extracellular matrix mineralization in G2 group was significantlyhigher than that of G1 group.CONCLUSION:Treatment with simvastatin(1×10-7mol/L)could promote osteoblastogenesis of HBMSCs in vitro,probably partially from activing TGF-β/BMPs signaling pathway and upregulating expression of its signaling moleculars.No change was found of expression levels of the detected genes of Wnt/β-catenin signaling pathway after simvastatin treatment,further study should be performed to detect the role of Wnt/β-catenin signaling pathway in osteoblastogenesis-promoting effect of simvastatin on hBMSCs.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To investigate the effects of simvastatin(SIM)on differentiation of osteoblast derived from the cultured human bone marrow stromal cells(hBMSCs).METHODS:hBMSCs derivedfrom human were cultured in vitro and divided into 2 groups:Control group(G1),SIM group(G2).After subculturing,the medium of treatment group(G2)were added 10-7M simvastatin.Real time RT-PCR was performed to evaluate the mRNA expressionsof BMP-2,Smad1,β-catenin,LRP5,Frizzled2 at day 7,14 and 21 after subculturing;The protein level expression of β-catenin was assessed by immuhistochemistry staining;Alkaline phosphatase staining was used to assess osteoblast differentiation at day 7 after subculturing;Von Kossa staining was used to assess extracellular matrix mineralization and at day 21 after subculturing.RESULTS:The expression levels of mRNA of BMP2 in group G2 were significantly higher than those of group G1 at 3 time points;The expression levels of mRNA of Smad1 in group G2 were significantly higher than those of group G1 at 14 and 21 d subculturing,and the mRNA expression levels of other detected genes showed no significant difference between two groups at each time point.Immuhistochemistry staining:No significant difference was found of the protein expression levels of β-catenin at the 3 time points between the 2 groups.the expression level of ALP and the capability of extracellular matrix mineralization in G2 group was significantlyhigher than that of G1 group.CONCLUSION:Treatment with simvastatin(1×10-7mol/L)could promote osteoblastogenesis of HBMSCs in vitro,probably partially from activing TGF-β/BMPs signaling pathway and upregulating expression of its signaling moleculars.No change was found of expression levels of the detected genes of Wnt/β-catenin signaling pathway after simvastatin treatment,further study should be performed to detect the role of Wnt/β-catenin signaling pathway in osteoblastogenesis-promoting effect of simvastatin on hBMSCs.
Key concepts: Simvastatin, Stromal cell, Osteoblast, Bone morphogenetic protein 2, Alkaline phosphatase, Extracellular matrix, Staining, Von Kossa stain